Loading clinical trials...
Loading clinical trials...
A Phase II Study Of Adjuvant Intravenous Irinotecan Following Resection With Or Without Radiofrequency Ablation (RFA), Of Hepatic Metastases From Colorectal Carcinoma
Conditions
Interventions
irinotecan hydrochloride
adjuvant therapy
+2 more
Locations
3
United States
Ireland Cancer Center
Cleveland, Ohio, United States
University of Washington School of Medicine
Seattle, Washington, United States
Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
May 1, 2001
Primary Completion Date
October 1, 2004
Completion Date
October 1, 2005
Last Updated
April 17, 2017
NCT07446322
NCT02600949
NCT05919264
NCT07541924
NCT07537491
NCT07536113
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions